bioAffinity Technologies
BIAFW
4 hedge funds and large institutions have $24.3K invested in bioAffinity Technologies in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
0.37% less ownership
Funds ownership: 3.37% → 3% (-0.37%)
8% less capital invested
Capital invested by funds: $26.3K → $24.3K (-$2.04K)
20% less funds holding
Funds holding: 5 → 4 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$961 |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$117 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $17.6K | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $2.68K | -$117 | -1,337 | -5% |
|
|
CS
3
Clear Street
New York
| $2.18K | – | – | – |
|
|
WAM
4
Warberg Asset Management
Winnetka,
Illinois
| $1.88K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$961 | -10,525 | Closed |
|
BIAFW Hedge Fund Activity: Q4 2023 in Review
4 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAFW) for Q4 2023, worth a combined $24.3K — down 7.7% from $26.3K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of BIAFW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, exiting entirely with an estimated $961 sold.
- 4 institutional investors held bioAffinity Technologies (BIAFW) as of Q4 2023, down from 5 in Q3 2023.
- Funds reported $24.3K of bioAffinity Technologies stock for Q4 2023, down 7.7% quarter-over-quarter.
- 0 funds opened new bioAffinity Technologies positions in Q4 2023 and 1 closed out, a net change of -1 holder.
- The largest bioAffinity Technologies seller in Q4 2023 was Susquehanna International Group, an estimated $961 sold.
Based on aggregated 13F filings for Q4 2023.